Defining How ADC Payloads Enhance Tumor Immunogenicity & Unlock Transformative Benefit With Immunotherapy
- Examining clinical ADC combinations with immunotherapy
- Differentiating ADC payloads by tumor-intrinsic immunogenic cell death (ICD) and activity on immune cells
- Assessing evidence of vedotin ADC immunogenicity in patients